BLACK WEEKSFlakoni −15% · komplekti −10% · pārējais −5%ar koduBezmaksas piegāde Vācijā no €200

Šī lapa ir tulkota automātiski un var saturēt kļūdas. Vai latviešu valoda ir jūsu dzimtā valoda? Mēs labprāt saņemsim jūsu atsauksmes un labojumus.Sūtīt atsauksmi

The Peptide Desk The Peptide Desk
Ezetimib, produkta foto
Medication

Ezetimib

Medication

  • Sūtām no Vācijas

Pasūtījums

Vienības cena - Bezmaksas piegāde Vācijā no 200 € Black Weeks laikā
  • DHL ar izsekošanu
  • Diskrēts iepakojums

4.6 no 5 Trustpilot73 atsauksmes

Īsumā

Ezetimib skaitļos

Galvenie rādītāji no mūsu leksikona. Velciet punktu pa līkni, lai redzētu, cik daudz paliek pēc vienas devas, pēc aprēķina.

Pilns leksikona ieraksts

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~22 hours

Half-life ~22 hours
After 44 hours: 25 %
Hour 2250 %Hour 24, next dose47 %Hour 4425 %Hour 6612.5 %Hour 1103.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon.

Half-life

about22hours

Class
Cholesterol absorption inhibitorNPC1L1 blocker
Use
Oral10mg once daily
Sizes
10 mg1 size in the shop

Produktam Ezetimib vēl nav laboratorijas analīzes. Balsot par toPasūtiet testu, mēs apmaksājam pusiVisas laboratorijas analīzes

Zināšanas

Viss par Ezetimib

FAQ

Bieži uzdotie jautājumi

Avoti katrai atbildei: leksikona ieraksts

Vēl ir jautājums?

Rakstiet mums, mūsu komanda jums palīdzēs.

Is ezetimibe approved?

Yes. ChEMBL lists ezetimibe with phase 4 as the highest phase and first approval in 2002, as a drug for raised cholesterol. ClinicalTrials.gov lists 491 trials with ezetimibe, as of 26 October 2026.

How does ezetimibe work?

It inhibits NPC1L1, a transporter at the brush border of small intestine cells that takes up cholesterol. Mice without NPC1L1 absorbed much less cholesterol and ezetimibe no longer worked in them. A year later a binding study showed that ezetimibe binds directly to NPC1L1.

How much does ezetimibe lower LDL?

Given alone, by 18.6 percent more than placebo on average, according to the meta-analysis of eight trials over 12 weeks. Total cholesterol fell by 13.5 percent, triglycerides by 8.1 percent and HDL rose by 3.0 percent.

What did IMPROVE-IT show?

18,144 people after an acute coronary syndrome received a statin plus ezetimibe or a statin plus placebo. LDL during the trial was 1.4 instead of 1.8 mmol/l. At 7 years 32.7 instead of 34.7 percent had a cardiovascular event. The difference is small, but it was the first large proof of added benefit from a non-statin.

How long does ezetimibe stay in the body?

The half-life is about 22 hours. Ezetimibe is converted in the gut and liver into an active glucuronide that returns to the gut via the bile. About 78 percent is excreted in the faeces.

Which side effects and interactions are known?

In SHARP and IMPROVE-IT muscle, liver and gallbladder events and cancer were about as common as in the comparison group. Bile acid sequestrants such as colestyramine clearly reduce ezetimibe uptake, ciclosporin raises its level. Fibrates raise it as well, according to the review probably of minor clinical relevance.

Saistītie

Saistītie produkti